Revenue, last quarter
$716M
+8.5% vs same quarter last year
Net income
$137.5M
+23.7% vs same quarter last year
EPS, diluted
$4.84
+25.4% vs same quarter last year
Operating cash flow
$216.6M
−12% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.5B | $451.1M |
| FY24 | $2.1B | $404.4M |
| FY23 | $1.9B | $282.8M |
| FY22 | $1.5B | $245.4M |
| FY21 | $1.1B | $181.8M |
| FY20 | $925.9M | $145.4M |
| FY19 | $861M | $100.4M |
| FY18 | $704.6M | $73.2M |
| FY17 | $436.2M | $39.1M |
| FY16 | $421.6M | $13.4M |
| FY15 | $359.1M | −$8.7M |
| FY14 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 21.1% | 17.8% |
| FY24 | 21.2% | 19.2% |
| FY23 | 17.9% | 15% |
| FY22 | 19.1% | 16.8% |
| FY21 | 17.4% | 15.9% |
| FY20 | 18% | 15.7% |
| FY19 | 14.8% | 11.7% |
| FY18 | 14.3% | 10.4% |
| FY17 | 14.9% | 9% |
| FY16 | 12.5% | 3.2% |
| FY15 | 5.7% | −2.4% |
| FY14 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $681.9M |
| FY24 | $572.3M |
| FY23 | $396.7M |
| FY22 | $351.2M |
| FY21 | $235.1M |
| FY20 | $227.3M |
| FY19 | $184M |
| FY18 | $140.6M |
| FY17 | $85.7M |
| FY16 | $78.2M |
| FY15 | $79.4M |
| FY14 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $917.4M |
| FY24 | $169.9M |
| FY23 | $144M |
| FY22 | $847.8M |
| FY21 | $62.1M |
| FY20 | $98.3M |
| FY19 | $0 |
| FY18 | $0 |
| FY17 | $155.6M |
| FY16 | $0 |
| FY15 | $0 |
| FY14 | - |
- Medpace
- Healthcare median
Show the numbers
| Year | Medpace | Healthcare median |
|---|---|---|
| FY25 | 17.8% | −30.6% |
| FY24 | 19.2% | −47% |
| FY23 | 15% | −58% |
| FY22 | 16.8% | −80.4% |
| FY21 | 15.9% | −71.9% |
| FY20 | 15.7% | −62.2% |
| FY19 | 11.7% | −46.3% |
| FY18 | 10.4% | −49.6% |
| FY17 | 9% | −45.9% |
| FY16 | 3.2% | −36% |
| FY15 | −2.4% | −38.4% |
| FY14 | - | −35.5% |